New Delhi, May 23, 2014 – Quality Council of India, Government of India has approved & certified Pharma Programmes in GMP, QA&QC and Regulatory Affairs. Under this approval, the diploma certificates for the post graduate & executive programmes will be awarded by Quality Council of India (QCI) and IGMPI jointly. Institute of Good Manufacturing Practices India, registered as a non-profit society with Government of India and a member (as a higher/professional Education Institute) of Quality Council of India(QCI) which is an autonomous body and an accreditation authority for education & vocational training providers under the Department of Industrial Policy & Promotion, Ministry of Commerce & Industry, Government of India -presents unique, friendly and interactive platform to get rid of all your GMP related glitches. GMP- is an essential element of industries like pharmaceutical, cosmetic, Ayurveda, biotech, homeopathic, medical device and food manufacturing. GMP in itself is the most dynamic part which witnesses frequent changes in terms of newer rules being added and older ones being renewed. Keeping self updated with current GMPs thus becomes inevitable to stay abreast with the changing industry needs and practices.
The Institute’s group of learned professionals from above mentioned sectors of the pharma and healthcare industries have put together their knowledge; know about and practical experiences in form of this GMP guide. IGMPI is moving hand in hand with technology advances and has gained recognition as stronger and better training & distance and e-learning platform provider for healthcare professionals in the areas of GMP, Quality Assurance and Control, Pharma and healthcare Regulatory Affairs, Pharma Product Management, Clinical Research, Pharmaceutical IPR and Good Laboratory Practice. The importance of quality healthcare is known to our founders and thus numerous efforts are being made to offer friendly but effective and easy online/distance sources of GMP information, Quality Assurance and Control, Pharma and healthcare Regulatory Affairs, Pharma Product Management, Clinical Research, Pharmaceutical IPR and Good Laboratory Practices in form of online seminars, distance/online courses as well as training programmes along with knowledge of worldwide affairs of the industry; in short a round-the-clock help for any information in these areas needed by anybody from around the world.
The IGMPI’s team of technology experts and other Industry advisors together pursue to make cGMP knowledge, training in the area of Pharma and healthcare manufacturing easily accessible, through this platform. The Institute currently offers Post Graduate and Executive Diploma Programmes in Pharma Good Manufacturing Practices (GMP), Quality Assurance & Quality Control, Regulatory Affairs, Product Management, IPR, Clinical Research & Good Laboratory Practices (GLP). These are imparted through Regular, Part time & Distance learning modes.
I n recent months the Institute has witnessed more and more participation from professionals working with global pharmaceutical, healthcare and food giants like Dr. Reddy’s Laboratories, Aurobindo Pharma, Glenmark Generics, Cipla, Wockhardt, Pfizer, Abbott, Medtronic, Foster Corporation, IPCA Laboratories, Calyx, Mother Dairy, Bliss GVS Pharma, Al Rawabi, Almarai, Green Pastures, SeQuent, PepsiCo India, Mankind, Beryl Drugs, Allergy Therapeutics, CFTRI, Ciron, Sun Pharmaceutical, Novartis, GlaxoSmithKline, Ranbaxy, Biocon etc.
IGMPI has already taken the initiative of providing with the Good Manufacturing Practices (GMP) guidelines and news updates to Pharma and healthcare professionals all over the world. This is published weekly and free for everyone. The perspective and coverage are international with special emphasis on US, UK, Europe, India, Australia, Canada, Japan, South Africa etc. Anyone can subscribe for the guidelines and news updates by registering his/her email id on the Institute’s website www.igmpiindia.org.
For more information and clarification, the contact details are +91 8130924488, +91 11 65353339 & email@example.com. CCI Newswire